The existing trial for it was to long and costly,and it`s obvious that they`ve heard that from partners,so making this change gets them interest for a partner and reduces the burn rate to 45 million. I`m sure once the new trial design is approved,we`ll then see who the partner is for it. With the Cervix market landscape changing,and having competition,it`s only smart to make this change to entice a partner,by reducing the cost of the trial and the turnaround time for results. It seems clear that they were advised to make this move,by experts who understand the landscape and what the partners of potential are looking for .